CorMedix (CRMD) Cash & Equivalents Growth (5y) (2015 - 2025)
CorMedix (CRMD) Cash & Equivalents Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CorMedix | 4.95 Mn | -150.26 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 80.18% |
| Sep 30, 2025 | 7.13% |
| Jun 30, 2025 | 57.39% |
| Mar 31, 2025 | 229.14% |
| Dec 31, 2024 | 19.98% |
| Sep 30, 2024 | 190.59% |
| Jun 30, 2024 | 178.11% |
| Mar 31, 2024 | 14.02% |
| Dec 31, 2023 | 202.76% |
| Sep 30, 2023 | 52.59% |
| Jun 30, 2023 | 158.23% |
| Mar 31, 2023 | 25.36% |
| Dec 31, 2022 | 202.07% |
| Sep 30, 2022 | 52.68% |
| Jun 30, 2022 | 23.32% |
| Mar 31, 2022 | 27.05% |
| Dec 31, 2021 | 45.90% |
| Sep 30, 2021 | 18.16% |
| Jun 30, 2021 | 43.48% |
| Mar 31, 2021 | 42.03% |